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Background: The Pain Self-Perception Scale (PSPS) is a 24-item questionnaire used to assess mental defeat in
chronic pain patients. The aim of this study was to develop a Spanish language version of the PSPS (PSPS-Spanish),
to assess the instrument’s psychometric properties in a sample of patients with fibromyalgia and to confirm a
possible overlapping between mental defeat and pain catastrophizing.
Methods: The PSPS was translated into Spanish by three bilingual content and linguistic experts, and then back-
translated into English to assess for equivalence. The final Spanish version was administered, along with the
Hospital Anxiety Depression Scale (HADS), Pain Visual Analogue Scale (PVAS), Pain Catastrophizing Scale (PCS) and
Fibromyalgia Impact Questionnaire (FIQ), to 250 Spanish patients with fibromyalgia.
Results: PSPS-Spanish was found to have high internal consistency (Cronbach’s a = 0.90 and the item-total
r correlation coefficients ranged between 0.68 and 0.86). Principal components analysis revealed a one-factor
structure which explained 61.4% of the variance. The test-retest correlation assessed with the intraclass correlation
coefficient, over a 1-2 weeks interval, was 0.78. The total PSPS score was significantly correlated with all the
questionnaires assessed (HADS, PVAS, PCS, and FIQ).
Conclusions: The Spanish version of the PSPS appears to be a valid tool in assessing mental defeat in patients
with fibromyalgia. In patients with fibromyalgia and Post-Traumatic Stress Disorder (PTSD), PSPS-Spanish correlates
more intensely with FIQ than in patients without PTSD. Mental defeat seems to be a psychological construct
different to pain catastrophizing.
Background
Mental defeat (MD) has been defined as the perceived
loss of autonomy in the face of uncontrollable traumatic
events, resulting in the person giving up efforts to retain
identity and self-will [1,2]. It has been implicated in the
development and maintenance of Post-Traumatic Stress
Disorder (PTSD) [1]. In the context of torture or assault,
mental defeat predicts not only the development and
severity of PTSD, but also the response to subsequent
treatment [1-4]. This construct has also been strongly
associated with the severity of depression, and the asso-
ciation remains highly significant even when hopeless-
ness is controlled for [5].
As both PTSD and depression are frequently comor-
bid with chronic pain, Tang et al [6] studied the concept
of mental defeat in chronic pain patients. They devel-
o p e das p e c i f i cq u e s t i o n n a i r et om e a s u r ei t ,t h eP a i n
Self-Perception Scale (PSPS), which showed adequate
psychometric properties. This questionnaire has not
been validated in other languages different from English,
and it has not been used in fibromyalgia (FM), a chronic
pain disorder”.
One of the problems in the development of the con-
struct “mental defeat” was its possible overlapping with
another psychological construct that is considered rele-
vant in chronic pain, pain catastrophizing (PC). PC is
considered a continuous psychological variable, normally
distributed even in healthy individuals without pain or
depression [7]. It has been described as an exaggerated
negative orientation toward noxious stimuli [8]. Tang
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catastrophizing, because the former is a type of catastro-
phizing focused not on the experience and meaning of
pain per se, but rather on the effects of pain as an
assault on the person’s life and sense of identity. In
addition, Tang et al [9] have demonstrated that, in
chronic pain patients, mental defeat emerged as the
strongest predictor of pain interference, depression and
psychosocial disability, whereas catastrophizing was the
best predictor of sleep interference, anxiety and func-
tional disability.
Despite mental defeat appearing to be a relevant con-
struct in chronic pain [6], it has not been previously
assessed in fibromyalgia (FM), one of the most prevalent
chronic pain syndromes. Another reason to assess MD
in FM is that PTSD and depression, the two psychiatric
disorders in which MD was originally studied, are fre-
quently comorbid in FM and even can influence its out-
come [10,11].
The aim of this paper is to validate the Spanish ver-
sion of Pain Self Perception Scale (PSPS-Spanish) in
patients with FM. Another secondary objective is to
confirm whether mental defeat is a concept that differs
from pain catastrophizing in patients with FM.
Methods
Translation process
Permission to translate and validate the PSPS was
obtained from the original authors [6]. Two Spanish-
speaking content experts (one psychiatrist and one psy-
chologist) and one Spanish-speaking linguistic expert
independently translated the PSPS into Spanish. Then,
the experts evaluated the Spanish versions, and any dis-
crepancies were discussed and rectified by consensus. A
professional Spanish-English translator with no knowl-
edge of the original English-language questionnaire inde-
pendently back-translated the combined Spanish
language questionnaire into English. The two content
experts then compared the original English version to the
backtranslated questionnaire. We have followed the usual
guidelines for cross-cultural adaptations [12]. This paper
is part of broader research on psychological constructs in
fibromyalgia and their validation in Spanish [13-15].
Participants
Sample size was calculated according to the recom-
mended 10:1 ratio of number of subjects to number of
test items [16]. The sample comprised consecutive
patients with FM recruited from primary care settings,
who were assessed at the Somatoform Disorders/FM
Unit at Miguel Servet University Hospital, Zaragoza,
Spain, during 2008. In order to be included in the study,
patients had to fulfill the American College of Rheuma-
tology criteria for primary FM [17], according to a
diagnosis made by a Spanish National Health Service
rheumatologist. The exclusion criteria were medical or
psychiatric disorders that impede the patient to answer
correctly the questionnaire, predominance of CFS symp-
toms, and poor knowledge of Spanish language. In 16
cases, CFS symptoms predominated, resulting in the
exclusion those patients from the study. The study ques-
tionnaires and protocol were approved by the Ethical
Committee of the regional health authority, and the
patients signed a consent form attesting to their willing-
ness to participate.
Assessments
Pain Self Perception Scale, Spanish version (PSPS-Spanish)
This is the questionnaire to be validated. It has 24 items,
with 11 items adapted from the PTSD mental defeat
scale [3,4] and 13 items adapted from the depression
defeat scale [5]. Respondents are asked to indicate to
what extent each of the 24 statements applied to their
experience “during a recent episode of intense pain”.
These statements are to be rated on a 5-point scale (0 =
“Not at all/Never,” 1=“Very little,” 2=“Moderately,” 3
= “Strongly,” 4=“Very strongly”), generating a total
score ranging from 0 to 96. The original English-lan-
guage version of this questionnaire has been demon-
strated to have adequate psychometric properties [6].
Fibromyalgia Impact Questionnaire (FIQ)
The FIQ is a 10-item self-report questionnaire that mea-
sures the health status of patients with FM [18]. The
first item focuses on patients’ ability to perform physical
activities. The following two items require the patients
to indicate the number of days in the past week they
felt good and how many days of work they missed. The
remaining seven items concern the ability to work, pain,
fatigue, morning tiredness, stiffness, anxiety, and depres-
sion and are measured with the visual analogue scale
(VAS). In the present study we used a Spanish version
of the FIQ that has been translated and validated [19].
Hospital Anxiety and Depression Scale (HADS)
The HADS [20] is a self-report scale that screens for the
presence of depression and anxiety in patients with
“medical conditions”. It comprises 14 items that are
rated on a 4-point Likert-type scale, and it is appropriate
for use in community and hospital settings. Two sub-
scales, HADS-Dep and HADS-Anx, independently assess
depression and anxiety. The HADS was previously vali-
dated in a Spanish population [21]. HADS was selected
for use in the present study because it is considered one
of the best questionnaires for assessing depression and
anxiety in patients with pain disorders [22].
Pain Visual Analogue Scale (PVAS)
The PVAS was designed to allow a subjective assess-
ment of pain. A Visual Analogue Scale is usually a 10-
cm horizontal line, with perpendicular lines on the
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The anchor points at each end are labeled as “No pain”
(accompanied by the number “0”) at one end and “maxi-
mum pain ever experienced” (accompanied by the num-
ber “100”) at the other end. Previous studies have
demonstrated PVAS to have adequate psychometric
properties [23].
Pain Catastrophizing Scale (PCS)
The PCS is a 13-item self-report questionnaire that
comprises three dimensions: (a) rumination, (b) magnifi-
cation and (c) helplessness. Its validity and reliability
have been previously reported [24]. Our group was
responsible for validating the Spanish version of this
questionnaire (15). There is no established “cut-off”
point because pain catastrophizing is considered a per-
sonality trait distributed in a continuous way in the gen-
eral population.
Standardized Polyvalent Psychiatric Interview (SPPI) [25]
This is a psychiatric interview developed by our group
for the multiaxial assessment of psychiatric morbidity in
medical patients. It permits the use of different diagnos-
tic criteria, including DSM-IV and International Classifi-
cation of Diseases, Tenth Revision (ICD-10). It was used
to diagnose psychiatric comorbidity in the sample.
Statistical analysis
In order to determine the suitability of the data for prin-
cipal components analysis, the Kaiser-Meyer-Olkin Mea-
sure of Sampling Adequacy (KMO) [26] and Bartlett’s
Test of Sphericity [27] were calculated. Internal consis-
tency was determined using Cronbach’s alpha and item-
total correlation coefficients. A principal components
analysis was then performed to determine whether the
24 items in the questionnaire could be combined into
separate components reflecting different aspects of men-
tal defeat. Varimax rotation was performed to minimize
the complexity of loadings for each component. Criter-
ion validity of the PSPS-Spanish was examined by calcu-
lating the correlations between the total PSPS-Spanish
score with the other questionnaires, using Pearson’s
r correlation coefficient. To confirm that pain catastro-
phizing and mental defeat are different constructs, a
partial correlation analysis between PSPS-Spanish and
the other scales controlling pain catastrophizing was
performed. Test-retest reliability, evaluated with the
intraclass correlation coefficient, was assessed for the 1
to 2-week follow-up interval, during which time the
patients did not change baseline treatment. All statistical
analyses were performed with SPSS software, Release 15
(SPSS Inc. Chicago, Illinois) except for the principal
component analysis, which was performed with LISREL




Differences between the original English-language
version and the back-translated version of the PSPS-
Spanish can be seen as Additional file 1. Most of the
twenty-four items of the PSPS-Spanish were back-trans-
lated identically to or with minor differences with the
original questionnaire. The final Spanish version is
shown in Table 1.
Characteristics of the sample
Sixteen patients were ruled out from the study because
CFS symptoms predominate. Of 253 potential subjects,
three (1.1%) declined to participate. None of the partici-
pants were ruled out because of the exclusion criteria.
T h ef i n a ls t u d ys a m p l ec o n s i s t e do f2 5 0p a t i e n t s ,2 2 9
(91.6%) women and 21 (8.4%) men, aged 24-61 (mean
44.9, SD: 7.2 years), all self-described as White
European. Ratio women: men are quite more frequent in
the sample reflecting a similar ratio in the prevalence of
FM in either gender. On average, the patients who parti-
cipated in the study had suffered from FM for 7.9 years
(range 1-20; SD: 2.3 years), and 122 (48.8%) had been
granted an invalidity pension. Most of the patients (231;
92.4%) were taking one or more prescription drugs. More
than half of the patients (N = 131; 52.4%) suffered from
some form of psychiatric morbidity assessed with SPPI,
mainly depression and anxiety. A group of 21 patients
(8.4%) were also diagnosed with PTSD.
Distribution of total scores
The distribution of PSPS-Spanish total score (M = 33.4,
S D=2 6 . 7 ,M i n i m u m=0 ,M a x i m u m=9 4 )d i dn o td i f -
fer significantly from a normal symmetric distribution
(skewness = 0.66, SE = 0.19; kurtosis = - 0.74; SE =
0.35), although there was a slight positive skew. There
were no significant differences in scoring between men
(M = 32.4, SD = 27.8) and women (M = 34.2, SD =
25.9). However, the subsample of patients with FM and
PTSD showed significantly higher scores in PSPS (M =
48.3, SD = 18.5) compared with the subgroup of
patients with FM but without PTSD (M = 31.2, SD =
28.3) (t =2 . 9 8 ,df =2 4 8 ,p < 0.01). Mean and SD scores
of the Spanish versions of the instruments used are
summarized in Table 2. There was not significant asso-
ciation between PSPS total score and most demographic
characteristics including gender, age, marital status,
duration of pain, education level or work status, as can
be seen in Table 3.
Face validity
For assessing face validity a subsample (N = 150) of the
validation study sample were randomly selected. They
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adequately measure the effects of pain as an assault on
the person’s life and sense of identity. A total of 95.3%
patients (143 out of 150) agreed.
Internal consistency
Cronbach’s a calculation for the 24 items in the PSPS-
Spanish was 0.90 (95% CI: 0.87-0.93), indicating a high
degree of internal consistency. Item-total r correlation
coefficients ranged between 0.68 and 0.86; median =
0.80) (Table 4).
Test-retest reliability
The response to the PSPS-Spanish provided by a ran-
dom subsample of 75 patients with fibromyalgia (gender
female: 70, 93.3%; age: mean 43.8 years, SD: 7.4 years;
duration of the disorders: mean 7.6 years SD: 2.5 years;
39 (52%) granted an invalidity pension) showed satisfac-
tory temporal stability of the scale over a 1-2 week
Table 1 Final Spanish version of the ESCALA DE AUTOPERCEPCIÓN DEL DOLOR
1.- Me sentí derrotado por la vida 0 - 1 - 2 - 3 - 4
2.- Sentí que había perdido mi lugar en el mundo 0 - 1 - 2 - 3 - 4
3.- Sentí que la vida me había tratado como a un saco de boxeo 0 - 1 - 2 - 3 - 4
4.- Me sentí impotente 0-1-2-3-4
5.- Sentí que me habían arrancado la confianza a golpes 0 - 1 - 2 - 3 - 4
6.- Me sentí incapaz de manejarme con las situaciones que la vida me enviaba 0 - 1 - 2 - 3 - 4
7.- Sentí que me había hundido hasta el fondo de la escalera 0 - 1 - 2 - 3 - 4
8.- Sentí que me habían dejado completamente inútil 0 - 1 - 2 - 3 - 4
9.- Sentí que era uno de los perdedores de la vida 0 - 1 - 2 - 3 - 4
10.- Sentí que me había rendido 0 - 1 - 2 - 3 - 4
11.- Me sentí fuera de combate 0 - 1 - 2 - 3 - 4
12.- Sentí que había perdido batallas importantes en la vida 0 - 1 - 2 - 3 - 4
13.- Sentí que no me quedaban fuerzas para luchar 0 - 1 - 2 - 3 - 4
14.- Sentí que estaba perdiendo mi fuerza de voluntad 0 - 1 - 2 - 3 - 4
15.- Ya no me importaba lo que me pudiese ocurrir 0 - 1 - 2 - 3 - 4
16.- Me sentí derrotado 0-1-2-3-4
17.- Sentí que era menos que un ser humano 0 - 1 - 2 - 3 - 4
18.- Tal como yo lo veía, me había rendido 0 - 1 - 2 - 3 - 4
19.- Me sentí destrozado como persona 0 - 1 - 2 - 3 - 4
20.- Sentí que me quería morir 0 - 1 - 2 - 3 - 4
21.- Sentí que había perdido mi resistencia emocional 0 - 1 - 2 - 3 - 4
22.- Me sentí como un objeto 0 - 1 - 2 - 3 - 4
23.- Me sentí completamente a merced de lo que me ocurría 0 - 1 - 2 - 3 - 4
24.- Me sentí humillado y que había perdido mi sentido de la dignidad 0 - 1 - 2 - 3 - 4
Este cuestionario trata sobre cómo se siente durante un episodio reciente de dolor. En él encontrará un número de afirmaciones que describen los pensamientos
y sentimientos que la gente a veces experimenta cuando sufre un episodio de dolor intenso. Por favor, puntúe la intensidad con las que estas afirmaciones se
aplican a su experiencia durante el episodio de dolor intenso marcando con un círculo el número apropiado. No hay respuestas correctas o equivocadas. Por
favor, recuerde que este cuestionario se refiere a cómo se siente usted durante los episodios de dolor intenso.
Table 2 Mean and SD scores of the Spanish versions of
the instruments used
Instruments (range) Mean SD
PSPS (0-96) 33.4 26.7
FIQ (0-100) 70.8 15.2
HADS-anx (0-21) 11.8 4.2
HADS-dep (0-21) 12.5 4.7
PVAS (0-100) 73.1 14.9
PCS (0-52) 30.8 11.7
Abbreviatures: PSPS: Pain Self-Perception Scale; FIQ: Fibromyalgia Impact
Questionnaire; HADS-anx: Hospital Anxiety Depression Scale, anxiety subscale;
HADS-dep: Hospital Anxiety Depression Scale, depression subscale; PVAS: Pain
Visual Analogue Scale; PCS: Pain Catastrophizing Scale.
Table 3 Association between the Spanish version of PSPS
and demographic parameters
Demographic parameters Association Significance
Gender 0.113 p = 0.192
Age 0.076 p = 0.653
Marital status 0.214 p = 0.342
Education level 0.198 p = 0.411
Duration of pain -0.096 p = 0.604
Work status 0.123 p = 0.093
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line treatment. The test-retest correlation assessed with
the intraclass correlation coefficient was 0.78.
Principal components analysis
The KMO was found to be 0.81, which exceeds the
recommended minimum value of 0.60 [26]. Bartlett’s
Test of Sphericity was highly significant (c2 = 753, p <
0.001), supporting the suitability of the data for principal
components analysis [26]. A one-component solution
was extracted using the Kaiser-Guttman rule (eigenva-
lues > 1.0) [28]. Results of the principal components
analysis are shown in Table 3. It yielded two factors
with eigenvalues greater than 1. The first factor, with an
eigenvalue of 13.8, explained 61.4% of the variance; the
second factor, with an eigenvalue of 1.9, explained only
7.3% of the total variance. All 24 items of the PSPS had
high loadings on the first factor, ranging from 0.69 to
0.86. When factor loading smaller than 0.4 was sup-
pressed, there was only 1 item loading on both factors
(item 22). Therefore, item 22 is considered a “crossload-
ing” item because it loaded high on more than one
factor. With these results and a visual inspection of the
scree plot, a one-factor solution is considered the most
appropriate.
Intercorrelations between PSPS-Spanish, depression,
anxiety, pain, global function and pain catastrophizing
The total PSPS-Spanish score was significantly asso-
ciated with all the questionnaires assessed (Table 5):
HADS-dep (r =0 . 6 3 ,p < 0.001), HADS-anx (r = 0.57,
p < 0.001), pain assessed with PVAS (r = 0.42, p <
0.001), global function assessed with FIQ (r =0 . 4 1 ,p <
0.001), and pain catastrophizing (r = 0.40, p <0.001).
Total SPSS in the subsample of patients with fibromyal-
gia and PTSD also show a significant association (p <
0.001) with all the questionnaires having similar Pear-
son’s r values to those of the whole sample: HADS-dep
(r =0 . 6 1 ) ,H A D S - a n x( r =0 . 5 5 ) ,P V A S( r = 0.44) and
pain catastrophizing (r = 0.42). However, PSPS correla-
tion with FIQ is much more important in this subsam-
ple (r = 0.63).
To confirm that pain catastrophizing and mental
defeat are different constructs, a partial correlation
Table 4 One-factor solution from Principal Component Analysis of the PSPS-Spanish
PSPS Item Factor loading
“Because of the pain... Factor 1 Factor 2 M SD Item-total r
19.- I felt destroyed as a person 0.86 0.04 1.21 1.43 0.86
16.- I felt defeated 0.86 -0.05 1.39 1.47 0.86
5.- I felt that my confidence had been knocked out of me 0.85 0.02 1.81 1.39 0.85
24.- I felt humiliated and that I was losing my sense of inner dignity 0.85 -0.08 1.32 1.41 0.85
3.- I felt that life had treated me like a punching bag 0.83 0.14 1.17 1.52 0.83
1.- I felt defeated by life 0.83 0.09 1.42 1.57 0.83
14.- I felt I was losing my will power 0.82 -0.12 1.28 1.45 0.81
9.- I felt I was one of life’s losers 0.82 0.17 1.09 1.33 0.82
23.- I felt completely at the mercy of what was happening to me 0.81 0.13 1.21 1.37 0.81
12.- I felt I had lost important battles in life 0.81 -0.07 1.34 1.43 0.81
2.- I felt that I had lost my standing in the world 0.80 -0.21 1.24 1.32 0.80
15.- I didn’t care what happened to me anymore 0.80 0.19 1.18 1.38 0.80
20.- I felt like I wanted to die 0.80 0.20 0.96 1.24 0.80
13.- I felt that there was no fight left on me 0.79 0.26 1.21 1.39 0.79
6.- I didn’t feel able to deal with things that life threw at me 0.79 -0.25 1.08 1.33 0.78
18.- In my mind, I gave up 0.77 0.28 1.10 1.24 0.77
21.- I felt like I was losing my inner resistance 0.77 -0.30 1.29 1.38 0.77
10.- I felt that I had given up 0.76 0.26 0.96 1.26 0.76
8.- I felt completely knocked out of action 0.76 0.32 1.89 1.52 0.76
11.- I felt down and out 0.74 0.35 1.27 1.42 0.74
17.- I felt less like a human being 0.72 -0.27 0.91 1.21 0.72
4.- I felt powerless 0.72 0.37 1.67 1.45 0.71
7.- I felt I had sunk to the bottom of the ladder 0.70 0.39 1.34 1.39 0.70
22.- I felt like an object 0.69 -0.43 0.92 1.14 0.68
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other scales controlling pain catastrophizing. The PSPS-
Spanish score was significantly associated with all the
questionnaires assessed, even those controlling pain cat-
astrophizing: HADS-dep (r = 0.51, p < 0.001), HADS-
anx (r = 0.48, p < 0.001), pain assessed with PVAS (r =
0.39, p < 0.001) and global function assessed with FIQ
(r = 0.38, p < 0.001).
Discussion
This study was undertaken to develop a Spanish lan-
guage version of the PSPS and to assess its psychometric
properties in FM patients. Additionally, one of its aims
was also to confirm whether or not mental defeat and
pain catastrophizing are overlapping concepts in patients
with FM. The psychological construct that assesses
PSPS, mental defeat, is expected to be important in pre-
dicting the outcome and in order to plan more effective
psychological treatments in patients with chronic pain,
including those with FM.
The sample of patients with FM in this study presents
the expected demographic and clinical characteristics of
this disorder: middle-aged women with several years of
duration of the disorder, and with frequent psychiatric
comorbidity and on invalidity pensions [29]. The preva-
lence of PTSD found was similar to that described in
previous papers [30]. The translation process was rela-
tively straightforward with only small differences
between the original and the back-translated version of
the questionnaire.
The psychometric properties of the PSPS-Spanish in
patients with FM were similart ot h o s eo ft h eo r i g i n a l
English-language validation study in chronic pain
patients [6]. Internal consistency reported in our study
was not as high as that reported by Tang et al. [6] (Cron-
bach’s a = 0.90 in our study compared to 0.98). A Cron-
bach’s a score of 0.90 may be more desirable, as it is well
above the acceptable limit of 0.70 [31]. A very high Cron-
bach’s a score indicates some degree of redundancy. This
has been acknowledged by Tang et al [6], who suggest
the need to develop a shorter version of the question-
naire. This may not be necessary in patients with FM.
Test-retest reliability was also satisfactory.
Similarly to the initial validation study [6], the principal
components analysis revealed a one-component solution
emphasizing that this questionnaire is a monolithic mea-
sure. These data could be expected because FM is a sub-
group of chronic pain patients and the selected sample
included patients for who pain, and not fatigue, was the
predominant symptom. Construct validity was evidenced
by significant correlations between the PSPS-Spanish
with all the questionnaires used in the validation process.
As expected, and was observed in the original study,
PSPS correlates with anxiety, depression and pain, but
the strength of the relationship was within the moderate
range (r = 0.42-0.63). We have included one measure of
global function, the FIQ, and PSPS-Spanish correlates
with this in a higher range in the subsample of patients
with FM that also suffer from PTSD (r = -0.63) than in
the whole sample (r = -0.41). This is coherent with other
studies that demonstrate MD as a predictor of severity
and chronicity in PTSD patients [1,2]. MD is expected to
be much more important in the outcome and therapeuti-
cal approach taken with this subsample. Finally, another
remarkable finding is the moderate correlation between
PTSD and PCS (r =0 . 4 0 ) ,s u g g e s t i n gt h a tM Da n dp a i n
catastrophizing are psychological constructs that are
related but distinguishable from each other. This finding
is also emphasized because MD measured by PSPS-Span-
ish is associated with depression, anxiety, pain and global
function even controlling pain catastrophizing. One lim-
itation of this study is that we did not assess the ques-
tionnaire in several populations, including healthy
individuals. As this was undertaken in the original valida-
tion study we did not consider it necessary.
Conclusion
The present study indicates that the Spanish version of the
measure of MD, the Pain Self-Perception Scale, has good
psychometric properties, including high levels of internal
Table 5 Interrelationship between mental defeat (PSPS), Pain, Anxiety, Depression, Catastrophizing and FIQ in
patients with fibromyalgia
1234 56
1.- Mental defeat (PSPS) –
2.- Global function (FIQ) 0.41*** –
3.- Depression (HADS-Dep) 0.63*** 0.54*** –
4.- Anxiety (HADS-Anx) 0.57*** 0.52*** 0.55*** –
5.- Pain (PVAS) 0.42*** 0.49*** 0.42*** 0.21* –
6.- Pain Catastrophizing (PCS) 0.40*** 0.62*** 0.53*** 0.28* 0.44*** –
*p < 0.05;
**p < 0.01;
***p <0 . 0 0 .
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ture is the same as that was found in the original validation
study. MD seems to be more important for global function
in patients with FM and with comorbid PTSD. MD and
pain catastrophizing are different psychological constructs
in patients with FM and also in chronic pain patients in
general, as have been previously demonstrated [9].
Additional material
Additional file 1: Back-translated version of the PSPS-Spanish. This
file compares the original English version of the PSPS questionnaire and
the back translated version of the PSPS.
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